Extract of un-audited standalone and consolidated financial results of the company for the quarter/half year ended 30.09.2025 published in free press English edition and choutha sansar ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medi-Caps Limited has submitted to BSE the newspaper publication of its unaudited financial results for the quarter and half year ended 30 September 2025, as required under SEBI LODR Regulation 47. On a standalone basis, the company posted a Q2 net profit of Rs 28.65 lakhs (down from Rs 44.54 lakhs in Q2 FY25), while reporting a small H1 loss of Rs 11.09 lakhs. Standalone revenue from operations stood at Rs 99.96 lakhs for the quarter. On a consolidated basis, performance weakened sharply — Q2 net loss was Rs 182.15 lakhs versus a profit of Rs 31.23 lakhs a year ago, with H1 FY26 consolidated loss of Rs 531.32 lakhs and total income falling to Rs 469.97 lakhs from Rs 829.62 lakhs in the prior-year period. Consolidated EPS turned negative at Rs -4.26 for H1 FY26. The results were approved by the Board on 12 November 2025.
Mixed to negative read-through: while standalone operations remain marginally profitable, the sharp deterioration on a consolidated basis — with revenue nearly halving and a Rs 531 lakh H1 loss — signals weakness in subsidiary performance and is likely to weigh on investor sentiment.